Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation
dc.authorid | SAHIN, TEVFIK TOLGA/0000-0002-9132-6115 | |
dc.authorid | Yilmaz, Sezai/0000-0002-8044-0297 | |
dc.authorid | ince, volkan/0000-0002-0714-490X | |
dc.authorid | Akbulut, Sami/0000-0002-6864-7711 | |
dc.authorid | BASKIRAN, ADIL/0000-0002-7536-1631 | |
dc.authorid | KARAKAS, SERDAR/0000-0001-8314-7806 | |
dc.authorid | Koc, Cemalettin/0000-0002-5676-6772 | |
dc.authorwosid | SAHIN, TEVFIK TOLGA/AAA-9648-2021 | |
dc.authorwosid | Yilmaz, Sezai/ABI-2323-2020 | |
dc.authorwosid | ince, volkan/M-7325-2017 | |
dc.authorwosid | Akbulut, Sami/L-9568-2014 | |
dc.authorwosid | BASKIRAN, ADIL/ABI-2356-2020 | |
dc.authorwosid | KARAKAS, SERDAR/AAB-3219-2021 | |
dc.authorwosid | Koc, Cemalettin/B-6430-2018 | |
dc.contributor.author | Baskiran, Adil | |
dc.contributor.author | Akbulut, Sami | |
dc.contributor.author | Sahin, Tevfik Tolga | |
dc.contributor.author | Koc, Cemalettin | |
dc.contributor.author | Karakas, Serdar | |
dc.contributor.author | Ince, Volkan | |
dc.contributor.author | Yurdaydin, Cihan | |
dc.date.accessioned | 2024-08-04T20:48:54Z | |
dc.date.available | 2024-08-04T20:48:54Z | |
dc.date.issued | 2020 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Purpose To evaluate the effect of hepatitis D virus (HDV) on hepatitis B virus-hepatocellular carcinoma (HBV-HCC) co-recurrence in patients undergoing living donor liver transplantation (LDLT) for HBV alone or HBV-HDV coinfection. Methods Between 2002 and 2019, 254 HBV-HCC patients underwent LDLT. The patients were divided into two groups after the application of the exclusion criteria: HBV-HCC (Group B;n = 163) and HBV-HDV-HCC (Group D;n = 31). First, the B and D groups were compared in terms of demographic and clinical parameters. Second, patients with (n = 16) and without (n = 178) post-transplant HBV-HCC co-recurrences were grouped and compared in terms of the same parameters. Results Although the risk of HBV-HCC co-recurrence in group D was 4.99-fold higher than in group B, the risk of HBV recurrence alone in group D was 12.5-fold lower than in group B. The AFP (OR = 4.4), Milan criteria (beyond; OR = 18.8), and HDV (OR = 8.1) were identified as the independent risk factors affecting post-transplant HBV-HCC co-recurrence. The Milan criteria (OR = 2.1) and HBV-HCC co-recurrence (OR = 10.9) were identified as the risk factors affecting post-transplant mortality. HBV-HCC co-recurrence developed in 26.5% of patients in Group B and 100% in Group D (OR = 40;p = 0.001). HCC recurrence alone developed in 10% of patients without HBV recurrence in group B and 0% of patients without HBV recurrence in group D (OR = 5.7). Conclusion This study showed that the risk of HBV recurrence alone was reduced by 12.5-fold in the presence of HDV; however, the HCC recurrence occurred in all patients with HDV when HBV recurrence developed. | en_US |
dc.identifier.doi | 10.1007/s12072-020-10085-3 | |
dc.identifier.endpage | 880 | en_US |
dc.identifier.issn | 1936-0533 | |
dc.identifier.issn | 1936-0541 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 32895876 | en_US |
dc.identifier.scopus | 2-s2.0-85090305845 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 869 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s12072-020-10085-3 | |
dc.identifier.uri | https://hdl.handle.net/11616/99522 | |
dc.identifier.volume | 14 | en_US |
dc.identifier.wos | WOS:000566873000001 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Hepatology International | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Liver transplantation | en_US |
dc.subject | HCC | en_US |
dc.subject | HBV | en_US |
dc.subject | HDV | en_US |
dc.subject | HBV recurrence alone | en_US |
dc.subject | HCC recurrence alone | en_US |
dc.subject | HBV-HCC co-recurrence | en_US |
dc.title | Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation | en_US |
dc.type | Article | en_US |